SUKARI, SUKARI
485  results:
Search for persons X
?
1

HyperlynX: A Phase 1b Safety Study of Xevinapant, Weekly Ci..:

Saba, N.F. ; Sukari, A. ; Forget, F....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e21 , 2024
 
?
2

A Phase 1 Dose-escalation and Expansion Study of CUE-101, G..:

Colevas, A.D. ; Chung, C.H. ; Adkins, D....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e87 , 2024
 
?
 
?
 
?
 
?
11

Novel combinations to overcome lenvatinib therapy resistanc..:

Sukari, A. ; Azmi, A.
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  5 - p. 1223-1224 , 2020
 
?
12

Association Between Radiation Therapy and PD-1 Inhibitors:

Patel, S. ; Abdallah, N. ; Nagasaka, M....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e165 , 2018
 
?
13

The Risks of Developing Hypothyroidism With Immune Checkpoi..:

Nagasaka, M. ; Alhasan, R. ; Abdallah, N....
International Journal of Radiation Oncology*Biology*Physics.  100 (2018)  5 - p. 1389 , 2018
 
?
14

Non–Small Cell Lung Cancer: Does Histology Matter?:

Nagasaka, M. ; Sukari, A.
International Journal of Radiation Oncology*Biology*Physics.  98 (2017)  1 - p. 227-228 , 2017
 
?
15

Pretreatment Computed Tomographic Gross Tumor Volume (CT-GT..:

Hurst, N.J. ; Dominello, M.M. ; Pereira, L.M....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  1 - p. S536-S537 , 2014
 
1-15